Placebo + Sativex® + THC Alone
Phase 3Completed 1 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Palliative Care
Conditions
Palliative Care, Pain, Cancer
Trial Timeline
Feb 1, 2002 → Mar 1, 2004
NCT ID
NCT00674609About Placebo + Sativex® + THC Alone
Placebo + Sativex® + THC Alone is a phase 3 stage product being developed by Jazz Pharmaceuticals for Palliative Care. The current trial status is completed. This product is registered under clinical trial identifier NCT00674609. Target conditions include Palliative Care, Pain, Cancer.
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00674609 | Phase 3 | Completed |